Additionally, CRFK cells have been shown to be unsuitable for the direct testing of the effects of angiotensin II (AT-II) on feline renal fibrosis [24], as well as in assessing the impacts of drugs that modulate this pathway, such as DOX [29]. The gene discussed is AGT; the disease is renal fibrosis.